Updates to the Management of Kidney Cancer

被引:27
作者
Jonasch, Eric [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, 1515 Holcombe Blvd,Unit 1374, Houston, TX 77030 USA
来源
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2018年 / 16卷 / 05期
关键词
RENAL-CELL CARCINOMA; ADJUVANT SUNITINIB; HIGH-RISK; TRIAL; NEPHRECTOMY; PLACEBO;
D O I
10.6004/jnccn.2018.0039
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Several updates were made to the 2018 NCCN Guidelines for Kidney Cancer. Adjuvant sunitinib is the first adjuvant therapy to be endorsed by the panel for patients with stage II and III clear cell histology renal cell carcinoma (RCC; category 2B). A promising new treatment-ipilimumab plus nivolumab for patients at intermediate and poor risk in the frontline setting-was added to the guidelines as well. Cabozantinib was added as a first-line option for poor- and intermediate-risk patients with advanced RCC.
引用
收藏
页码:639 / 641
页数:3
相关论文
共 9 条
[1]  
Choueiri TK, 2017, 2017 ESMO C SEPT 8 1
[2]  
Escudier B, 2017, 2017 ESMO C SEPT 8 1
[3]   Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial [J].
Haas, Naomi B. ;
Manola, Judith ;
Uzzo, Robert G. ;
Flaherty, Keith T. ;
Wood, Christopher G. ;
Kane, Christopher ;
Jewett, Michael ;
Dutcher, Janice P. ;
Atkins, Michael B. ;
Pins, Michael ;
Wilding, George ;
Cella, David ;
Wagner, Lynne ;
Matin, Surena ;
Kuzel, Timothy M. ;
Sexton, Wade J. ;
Wong, Yu-Ning ;
Choueiri, Toni K. ;
Pili, Roberto ;
Puzanov, Igor ;
Kohli, Manish ;
Stadler, Walter ;
Carducci, Michael ;
Coomes, Robert ;
DiPaola, Robert S. .
LANCET, 2016, 387 (10032) :2008-2016
[4]   Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Agents: Results From a Large, Multicenter Study [J].
Heng, Daniel Y. C. ;
Xie, Wanling ;
Regan, Meredith M. ;
Warren, Mark A. ;
Golshayan, Ali Reza ;
Sahi, Chakshu ;
Eigl, Bernhard J. ;
Ruether, J. Dean ;
Cheng, Tina ;
North, Scott ;
Venner, Peter ;
Knox, Jennifer J. ;
Chi, Kim N. ;
Kollmannsberger, Christian ;
McDermott, David F. ;
Oh, William K. ;
Atkins, Michael B. ;
Bukowski, Ronald M. ;
Rini, Brian I. ;
Choueiri, Toni K. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (34) :5794-5799
[5]   Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma [J].
Motzer, RJ ;
Mazumdar, M ;
Bacik, J ;
Berg, W ;
Amsterdam, A ;
Ferrara, J .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2530-2540
[6]  
Motzer RJ, 2018, 2018 GEN CANC S FEBR
[7]   Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma [J].
Motzer, Robert J. ;
Haas, Naomi B. ;
Donskov, Frede ;
Gross-Goupil, Marine ;
Varlamov, Sergei ;
Kopyltsov, Evgeny ;
Lee, Jae Lyun ;
Melichar, Bohuslav ;
Rini, Brian I. ;
Choueiri, Toni K. ;
Zemanova, Milada ;
Wood, Lori A. ;
Reaume, M. Neil ;
Stenzl, Arnulf ;
Chowdhury, Simon ;
Lim, Ho Yeong ;
McDermott, Ray ;
Michael, Agnieszka ;
Bao, Weichao ;
Carrasco-Alfonso, Marlene J. ;
Aimone, Paola ;
Voi, Maurizio ;
Doehn, Christian ;
Russo, Paul ;
Sternberg, Cora N. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (35) :3916-+
[8]   Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy [J].
Ravaud, A. ;
Motzer, R. J. ;
Pandha, H. S. ;
George, D. J. ;
Pantuck, A. J. ;
Patel, A. ;
Chang, Y. -H. ;
Escudier, B. ;
Donskov, F. ;
Magheli, A. ;
Carteni, G. ;
Laguerre, B. ;
Tomczak, P. ;
Breza, J. ;
Gerletti, P. ;
Lechuga, M. ;
Lin, X. ;
Martini, J. -F. ;
Ramaswamy, K. ;
Casey, M. ;
Staehler, M. ;
Patard, J. -J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (23) :2246-2254
[9]   Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial [J].
Rini, Brian I. ;
Dorff, Tanya B. ;
Elson, Paul ;
Suarez Rodriguez, Cristina ;
Shepard, Dale ;
Wood, Laura ;
Humbert, Jordi ;
Pyle, Linda ;
Wong, Yu-Ning ;
Finke, James H. ;
Rayman, Patricia A. ;
Larkin, James M. G. ;
Garcia, Jorge A. ;
Plimack, Elizabeth R. .
LANCET ONCOLOGY, 2016, 17 (09) :1317-1324